Hints and tips:
Related Special Reports
...Leqembi, priced at $26,500 a year, was the first drug with a black-box warning — the most severe designation about possible side effects — to be granted full approval by the US Food and Drug Administration...
...A decision from the US Food and Drug Administration on Eli Lilly’s donanemab drug was originally due by the end of the first quarter but the breakthrough medicine will now be subject to a further review...
...These will be the first results from a study designed around landmark US Food and Drug Administration guidelines for researching psychedelics that were outlined last year, a decision that encouraged investors...
...Soon after Mexico’s president took office in 2018, agents of the US Drug Enforcement Administration knew their job was about to become a lot more difficult....
...A decision on Eli Lilly’s donanemab drug from the US Food and Drug Administration was originally due by the end of the first quarter, but the medicine will now be subject to a further review by an advisory...
...AstraZeneca chief executive Pascal Soriot said last month that the company planned to build independent drug supply chains for the US and China....
...Eli Lilly said that it plans to submit the results to the US Food and Drug Administration and other medicine regulators worldwide to seek approval for tirzepatide as a sleep apnoea treatment beginning this...
...The US biotech company reported first-quarter earnings of $3.67 a share, beating analysts’ consensus estimates of $3.44. That pushed Biogen’s shares up 4.3 per cent in early trading on Wednesday....
...The US Food and Drug Administration will allow Florida to import medicines from Canada, making it the first state to capitalise on rules designed to lower the cost of prescription drugs....
...“There’s been a lot of noise about drugs that are illicit or copies or compounded versions of Zepbound or other weight loss drugs and that’s concerning to us and I think it’s concerning to patients, so by...
...Novo Nordisk’s Wegovy medication, which this month received US Food and Drug Administration approval to help reduce heart attack and stroke risk in patients with a history of cardiovascular problems, can...
...Emblaveo was developed in partnership with US pharma company AbbVie and with financial support from US and EU public bodies....
...“Drug trafficking gangs such as Los Choneros, many with ties to powerful drug cartels in Mexico, threaten the lives and livelihoods of communities in Ecuador and throughout the region,” Brian Nelson, the...
...The US Food and Drug Administration and the UK’s Medicines and Healthcare products Regulatory Agency said patients in clinical trials of Lilly’s tirzepatide had seen “significant” weight loss compared with...
...Yet the Biden administration has also been a stalwart ally and supporter of Israel as it prosecutes its war against Hamas in Gaza, despite mounting international opprobrium....
...Scientists have invented a potential drug candidate that successfully combats antibiotic-resistant “superbugs” in non-human tests, according to research....
...The US Food and Drug Administration has approved the first Alzheimer’s drug that can slow the progression of the neurodegenerative disease, paving the way for millions of American patients to access the...
...Tranq was first detected in an opioid-related death in the US in 2006....
...For decades, US prosecutors have extradited and tried former Latin American officials for ties to drugs, but the prosecution against Hernández was unusually swift....
...The rush to secure manufacturing capacity comes as Wegovy and Mounjaro, which is also commonly prescribed off-label for weight loss, are in short supply, according to the US Food and Drug Administration....
...on behalf of the Food and Drug Administration....
...insurers to cover the drug....
...The US Food and Drug Administration recently approved the first-ever drug designed specifically for the most common liver disease, metabolic dysfunction-associated steatohepatitis or mash, developed by Madrigal...
...The drug is marketed by Sanofi as Lyxumia in the EU and Adlyxin in the US, where it was discontinued last year because of low demand....
International Edition